ArticleMolecular oncology2015

Upregulated interleukin-6 expression contributes to erlotinib resistance in head and neck squamous cell carcinoma.

Aditya Stanam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.